Articles

Anthem increases its hold on Indiana

Anthem Insurance Co. added nearly 75,000 commercial customers last year, pushing its total up more than 4 percent. Anthem,
a subsidiary of Indianapolis-based WellPoint Inc., now claims a whopping 1.8 million commercial customers in the state. The
trouble is, Anthem’s dominance limits price competition, according to benefits brokers, making it hard for local HMOs such
as M-Plan or even some national players to compete.

Read More

Indy beverage acquirer scores first purchase: Taliera drinks up Texas maker of Bloody Mary mix

It took a year and a half. But Indianapolis-based Taliera Holdings LLC finally acquired its first beverage brand. Taliera, led by Indianapolis entrepreneur J. Smoke Wallin, acquired Texasbased Red Eye Brands this month. The company makes Red Eye Bloody Mary mix, as well as salsas and sauces. Terms of the deal were not disclosed. But Wallin said Red Eye holds less than 5 percent of the Bloody Mary mix market. He hopes to take the company to 10 percent three…

Read More

Roche to move 340 into Marsh offices

Growth at Roche Diagnostics will push across 96th Street and take over the Marsh Supermarkets headquarters building, Roche announced today. By the end of 2010, Roche will transfer roughly 340 jobs to the new location from its campus in the northeast corner of Marion County, which serves as the company’s North American headquarters. Swiss-based Roche, […]

Read More

BREAKING: Is Conseco for sale?

Conseco Inc. reported today that it has been working with investment bank Morgan Stanley for months to explore “strategic alternatives” for the company – a phrase often used when a company is searching for a buyer. Carmel-based Conseco made the announcement this morning as it declined a request from one of its largest investors, Steel […]

Read More

Anthem pitching new wellness program to employers: Insurer rolls out 360* Health program in Indiana

* Health program in Indiana To Randy Reichmann, warning workers about unhealthy lifestyles was nothing new. But it took just four words for a new wellness program from Anthem Blue Cross and Blue Shield to grab his attention: free gym membership-citywide. “You can’t just say, that’s bad for you. You have to say what you’re going to do that’s good for you,” said Reichmann, president of the Indianapolis region for Old National Bank. The Evansville-based bank is the first Indiana employer…

Read More

Lilly strikes $7M-plus licensing deal

Eli Lilly and Co. will pay at least $7 million to acquire rights to a diabetes compound developed by Toronto-based Transition Therapeutics Inc., the companies announced tonight. Indianapolis-based Lilly will work with Transition to complete a Phase II trial of a compound called TT-223, which provided sustained improvement in blood sugar control during preclinical studies. […]

Read More

Another noose found at Lilly, law firm claims

A law firm pressing a racial discrimination lawsuit against Eli Lilly and Co. says a security guard found a noose hanging in a tree on Lilly’s corporate campus in Indianapolis. Rose & Rose, a Washington, D.C., law firm, sent a statement about the incident late yesterday. The law firm is representing a group of current […]

Read More

WellPoint news could presage industry slump

WellPoint Inc.’s woes made for a gloomy day on Wall Street and could turn into year-long gloom for the whole industry. That’s what at least one Wall Street firm said after Indianapolis-based WellPoint sharply lowered its profit forecast late yesterday. Its share price fell 26 percent this morning, to $48.55. Goldman Sachs and Co. slashed […]

Read More

Lilly drops inhaled-insulin project

Eli Lilly and Co. confirmed this evening that it will abandon its inhaled insulin program, citing increased uncertainties about its commercial potential and the regulatory environment. The decision will cost Lilly $90 million to $120 million, or from 5 to 7 cents per share. The Indianapolis-based drugmaker now expects to per-share profit of $3.73 to […]

Read More

Partner: Lilly may halt inhaled insulin project

The company helping Eli Lilly and Co. develop inhaled insulin said it expects Lilly to scuttle the project next week. Massachusetts-based Alkermes Inc. said in a news release this morning that Lilly officials have told the company they are evaluating the business prospects for inhaled insulin, called AIR Insulin. Alkermes’ statement said company officials are […]

Read More

Local dentists cut their teeth on wellness: Larger office extends efforts to address total health

When dentists Harold Smith and Ted Brauer built their new office, they constructed more than a third more space than they needed for patients. With the rest, Smith and Brauer started a health and wellness center that local not-for-profits can use free of charge. So in addition to the whir of drill motors, their Castleton office frequently resonates with sounds of cooking classes, “gymborees” for kids, health screenings and health-related seminars. “Excellence in dentistry is who we are. But we…

Read More

Conseco retains manager appeal: Amid ongoing struggles, insurer landing top talent

Ten years ago, Dan Bardin was exactly where he wanted to be. He was running insurance operations for behemoth American International Group in Thailand, as Asian financial markets collapsed. “I was there right in the middle of the crisis. And that’s what I like,” Bardin said. Today, Bardin has found his way to another crisis of sorts. He’s the new president of the Conseco Insurance Group. During the year leading up to Bardin’s arrival in December, the subsidiary of Carmel-based…

Read More

UPDATE: Lilly shares slip following Zyprexa news

Shares of Eli Lilly and Co. fell this morning after the company announced regulators had rejected its application for a long-acting, injectible version of its best-selling drug, Zyprexa. Lilly’s stock price fell roughly 2 percent, to $50.73. The U.S. Food and Drug Administration said in a “not approvable” letter that it needs more information on […]

Read More

FDA rebuffs long-acting Zyprexa

Eli Lilly and Co. has been rejected in its attempt to win approval for a long-acting, injectible version of its best-selling drug, Zyprexa. The U.S. Food and Drug Administration told the Indianapolis-based drugmaker in a “not approvable letter” that it needs more information on the medicine’s major side effect, excessive sleepiness, the Indianapolis drugmaker announced […]

Read More

Community to expand South hospital

Community Health Network plans to announce a $130 million expansion of its Community Hospital South on Thursday. The city’s third-largest hospital chain said the expanded hospital would help “meet demand of (the) growing south market,” according to a press statement. The hospital is located on the north side of County Line Road. Less than a […]

Read More

UPDATE: Conseco shares slip after report

Stock in Conseco Inc. sank 4 percent this morning after the Carmel insurer said it would restate earnings for nearly the past three years and alter other information as far back as 2003. The shares slumped to $11.62. Conseco said the action will correct errors identified by the company’s process of improving its internal financial […]

Read More

SEC pushes Lilly, WellPoint for more info on executive pay: Two Indianapolis companies are among 350 queried

The U.S. Securities and Exchange Commission wants to know more about how Eli Lilly and Co. and WellPoint Inc. decide how to pay their top executives. The two Indianapolis companies exchanged letters last fall with the SEC. The federal agency requested more information about executive compensation from 350 of the nation’s largest public companies. The correspondence led Lilly to include more detailed information in a preliminary version of its proxy statement that it filed Feb. 6. WellPoint officials have promised…

Read More

UnitedHealthcare, Indiana Orthopaedic sign pact

UnitedHealthcare has signed a three-year contract with the Indiana Orthopaedic Hospital, bringing the specialty hospital into UnitedHealthcare’s central Indiana network of health care providers. The contract, announced today, took effect on Feb. 1. It gives the orthopedic hospital “in-network” status, which typically means bigger discounts for UnitedHealthcare customers. OrthoIndy, a group of more 60 orthopedic […]

Read More